In new trouble for the government's billion-dollar bioterrorism program, the FDA has accused VaxGen of making exaggerated claims of the purity and effectiveness of a new anthrax vaccine. The agency threatened court action unless VaxGen swiftly corrected the claims. VaxGen declined to comment.
- here's the report from The Washington Post